Literature DB >> 8500155

Transformed migraine.

N T Mathew1.   

Abstract

Chronic tension-type headache, which is included in the International Headache Classification, is present in only a minority of patients who present with chronic daily headache. The majority have what is termed transformed migraine, with a history of distinct episodes of migraine in the initial years which progresses into chronic daily headache. These patients with transformed migraine exhibit mixed features of migraine and chronic tension-type headache. Two distinct types of transformed migraine are identifiable, namely those related to excessive intake of medications (drug-induced transformed migraine) and those unrelated to excessive use of medications. The clinical features of transformed migraine and the drug-induced variety are described. The need for revision of the International Classification to include chronic daily headache and the subtypes of transformed migraine is pointed out.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500155     DOI: 10.1177/0333102493013S1217

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  27 in total

Review 1.  Sinus venous stenosis, intracranial hypertension and progression of primary headaches.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Pasquale Persico; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 2.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

Authors:  Roberto De Simone; Angelo Ranieri; Chiara Fiorillo; Leonilda Bilo; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

Review 4.  ICHD-3: what changes do we need regarding migraine?

Authors:  Gian Camillo Manzoni; Ilaria Grisendi; Paola Torelli
Journal:  Curr Pain Headache Rep       Date:  2011-06

5.  Sinus venous stenosis-associated idiopathic intracranial hypertension without papilledema as a powerful risk factor for progression and refractoriness of headache.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Vincenzo Bonavita
Journal:  Curr Pain Headache Rep       Date:  2012-06

6.  Adverse reactions related to drugs for headache treatment: clinical impact.

Authors:  Anna Ferrari; Alessandra Ottani; Alfio Bertolini; Arrigo Francesco Giuseppe Cicero; Ciro Pio Rosario Coccia; Sheila Leone; Emilio Sternieri
Journal:  Eur J Clin Pharmacol       Date:  2005-01-19       Impact factor: 2.953

Review 7.  Drug overuse and rebound headache.

Authors:  Stephen D Silberstein; Dongmei Liu
Journal:  Curr Pain Headache Rep       Date:  2002-06

8.  Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation.

Authors:  Kenneth A Holroyd; Jennifer S Labus; Francis J O'Donnell; Gary E Cordingley
Journal:  Headache       Date:  2003-10       Impact factor: 5.887

9.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

Review 10.  The differential diagnosis of chronic daily headaches: an algorithm-based approach.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  J Headache Pain       Date:  2007-10-23       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.